Sintilimab Combined with Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma in Second-Line Setting-A Multi-Center Observational Study
FRONTIERS IN ONCOLOGY（2022）
关键词
intrahepatic cholangiocarcinoma,sintilimab,lenvatinib,second-line treatment,PD-L1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要